Valo Therapeutics Oy

04/22/2024 | Press release | Archived content

Leadership Change

Paul Higham recently resigned as CEO of the company and will leave in May to pursue other opportunities. Sari Pesonen, co-founder and currently Chief Scientific Officer, will take over as CEO in early May.


Matti Hautsalo commented on behalf of the Board:

'We would like to thank Paul for his service to the company over the past almost 4 years and wish him well for the future. Sari co-founded the company in 2016 and has led the scientific development of the company since then becoming Chief Scientific Officer in 2021. The Board is looking forward to working with Sari and the rest of the management team as the company moves on to the next stage of the company's evolution'

Valo Therapeutics Oy published this content on April 22, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 11:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]